NASDAQ:SRTS Sensus Healthcare (SRTS) Stock Price, News & Analysis $3.19 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$3.20 +0.00 (+0.16%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Sensus Healthcare Stock (NASDAQ:SRTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sensus Healthcare alerts:Sign Up Key Stats Today's Range$3.16▼$3.2850-Day Range$3.08▼$4.4952-Week Range$2.82▼$5.92Volume38,049 shsAverage Volume83,263 shsMarket Capitalization$52.51 millionP/E RatioN/ADividend YieldN/APrice Target$6.88Consensus RatingModerate Buy Company Overview Sensus Healthcare, Inc. is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company’s SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare’s systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients. The company’s flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls. These systems allow dermatologists and radiation oncologists to administer precise doses of radiation directly to lesions while sparing surrounding healthy tissue. In addition to its hardware, Sensus Healthcare offers training, credentialing support and treatment planning assistance, helping clinics and hospitals integrate SRT into their service offerings and meet regulatory requirements. Founded in 2004 and headquartered in Jacksonville, Florida, Sensus Healthcare has built a network of clinical partners and distributors across the United States and select international markets. The company’s sales and service organization works closely with dermatology practices, oncology centers and academic institutions to facilitate device installation, maintenance and ongoing technical support. Over time, Sensus Healthcare has expanded its outreach through strategic collaborations with key opinion leaders and specialty societies to raise awareness of superficial radiation therapy protocols and best practices. Under the leadership of President and CEO R. Scott Ruskin, Sensus Healthcare continues to pursue research and development initiatives aimed at broadening the clinical applications of its SRT technology. The company remains focused on generating long-term data on treatment efficacy and patient outcomes, while exploring opportunities to enhance device capabilities and workflow integration. With a growing installed base and a commitment to education and clinical validation, Sensus Healthcare positions itself as a dedicated provider of non-invasive radiation therapy solutions for dermatology and oncology practitioners.AI Generated. May Contain Errors. Read More Sensus Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreSRTS MarketRank™: Sensus Healthcare scored higher than 67% of companies evaluated by MarketBeat, and ranked 224th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingModerate Buy Consensus RatingSensus Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialSensus Healthcare has a consensus price target of $6.88, representing about 115.5% upside from its current price of $3.19.Amount of Analyst CoverageSensus Healthcare has only been the subject of 3 research reports in the past 90 days.Read more about Sensus Healthcare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is -6.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is -6.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Sensus Healthcare's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.09% of the float of Sensus Healthcare has been sold short.Short Interest Ratio / Days to CoverSensus Healthcare has a short interest ratio ("days to cover") of 9.24.Change versus previous monthShort interest in Sensus Healthcare has recently decreased by 26.71%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.08 News SentimentSensus Healthcare has a news sentiment score of -0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Sensus Healthcare this week, compared to 2 articles on an average week.Search Interest2 people have searched for SRTS on MarketBeat in the last 30 days. Company Ownership2.8 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $4,995.00 in company stock, which represents 0.0095% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,995.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.20% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions25.30% of the stock of Sensus Healthcare is held by institutions.Read more about Sensus Healthcare's insider trading history. Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRTS Stock News HeadlinesHow The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement ChangesMay 20, 2026 | finance.yahoo.comSensus Healthcare Balances Weak Quarter With Growth CatalystsMay 20, 2026 | tipranks.comThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.May 25 at 1:00 AM | Behind the Markets (Ad)Analysts Set Sensus Healthcare, Inc. (NASDAQ:SRTS) PT at $6.88May 19, 2026 | americanbankingnews.comSensus outlines full year profitability goal for 2026 as new CPT codes take effectMay 8, 2026 | seekingalpha.comSensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2026 Earnings Call TranscriptMay 8, 2026 | insidermonkey.comSensus Healthcare Charts Recovery Path Amid Revenue DropMay 8, 2026 | tipranks.comSensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure OncologyMay 8, 2026 | businesswire.comSee More Headlines SRTS Stock Analysis - Frequently Asked Questions How have SRTS shares performed this year? Sensus Healthcare's stock was trading at $3.98 at the beginning of the year. Since then, SRTS shares have decreased by 19.8% and is now trading at $3.19. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) released its quarterly earnings results on Thursday, May, 7th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.04. The company earned $3.39 million during the quarter, compared to analyst estimates of $5.32 million. Sensus Healthcare had a negative net margin of 34.50% and a negative trailing twelve-month return on equity of 15.79%. Read the conference call transcript. When did Sensus Healthcare IPO? Sensus Healthcare (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. Who are Sensus Healthcare's major shareholders? Sensus Healthcare's top institutional shareholders include Dimensional Fund Advisors LP (2.35%), Renaissance Technologies LLC (1.53%), North Star Investment Management Corp. (0.76%) and Bank of New York Mellon Corp (0.61%). Insiders that own company stock include Joseph C Sardano, Eric Sachetta, Michael Sardano and John Heinrich. View institutional ownership trends. How do I buy shares of Sensus Healthcare? Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CrowdStrike (CRWD), EMCOR Group (EME), e.l.f. Beauty (ELF) and Arista Networks (ANET). Company Calendar Last Earnings5/07/2026Today5/25/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, SRTS's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SRTS CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees40Year Founded2010Price Target and Rating Average Price Target for Sensus Healthcare$6.88 High Price Target$8.00 Low Price Target$6.00 Potential Upside/Downside+115.5%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.72 million Net Margins-34.50% Pretax Margin-50.57% Return on Equity-15.79% Return on Assets-14.02% Debt Debt-to-Equity RatioN/A Current Ratio7.27 Quick Ratio4.03 Sales & Book Value Annual Sales$27.48 million Price / Sales1.91 Cash FlowN/A Price / Cash FlowN/A Book Value$2.77 per share Price / Book1.15Miscellaneous Outstanding Shares16,460,000Free Float14,783,000Market Cap$52.51 million OptionableOptionable Beta1.19 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:SRTS) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
